神経疾患の主要な要因であるMeCP2は,転写を活性化し抑制する
Maria Chahrour1, Sung Yun Jung, Chad Shaw
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
まとめ
メチル-CpG結合タンパク質2 (MeCP2) 機能障害は神経精神疾患を引き起こす. 研究によると,MeCP2は数千の下垂体遺伝子を調節し,活性化剤と抑制剤の両方として作用します.
科学分野:
- 神経科学は神経科学である.
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
背景:
- メチル-CpG結合タンパク質2 (MeCP2) 遺伝子の変異がレット症候群を引き起こす.
- MeCP2遺伝子の機能障害は,機能の喪失と投与量の増加を含む様々な神経精神疾患と関連しています.
研究 の 目的:
- MeCP2に関連する疾患の分子メカニズムを調査する.
- MeCP2機能不全のマウスの下垂体における遺伝子発現パターンを検査する.
主な方法:
- MeCP2.2が欠けているか,過剰に発現しているマウス下垂体モデルにおける遺伝子発現の分析.
- MeCP2が標的遺伝子プロモーターに結合することを確認した.
- 転写活性化剤CREB1.1とのMeCP2関連性の調査
主要な成果:
- MeCP2の機能障害は,下垂体にある何千もの遺伝子の発現を変化させた.
- 影響を受けた遺伝子の約85%がMeCP2.2によって意外に活性化されました.
- MeCP2はプロモーターと結合し,活性化された標的遺伝子でCREB1と結合することが示されました.
結論:
- MeCP2は,視床下部内の幅広い遺伝子を調節する上で重要な役割を果たします.
- MeCP2は,転写活性化剤と抑制剤の両方として機能し,異なるメカニズムを通じて遺伝子発現に影響を与えます.
関連する概念動画
Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
RNA Polymerase II Accessory Proteins
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...


